Review
Copyright ©The Author(s) 2024.
World J Hepatol. Apr 27, 2024; 16(4): 566-600
Published online Apr 27, 2024. doi: 10.4254/wjh.v16.i4.566
Table 7 Effects and molecular mechanisms underlying MgONPs induced hepatonanotoxicity
NPs
Size
Tested model
Dose & route of administration
Effects & mechanism
Ref.
MgO-3D Human Liver organoids male Sprauge Dawley rat100 μg/mL incubated for 48 h. 40 mg/kg daily for 4 wk (oral)ATP synthesis (decreased); ROS & Super oxide production (increased); ALT, AST (increased)[21]
Oxidative stress